Fig. 2From: Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysisForest plots for the pooled incidence of acute GVHD (a MSCs group; b no MSCs group), grade II–IV acute GVHD (c MSCs group; d no MSCs group), and chronic GVHD (e MSCs group; f no MSCs group)Back to article page